News & Events


Antidepressant may help combat the course of multiple sclerosis

Antidepressant may help combat the course of multiple sclerosis


Did you hear me Mickey ?

Did you hear me Mickey ?


Interview Jean-François Gouzer – CEO, Scientis Pharma

Interview Jean-François Gouzer – CEO, Scientis Pharma, Switzerland -Life Sciences Incubator Fondation Eclosion.


Wonderful holiday season and a happy and prosperous 2018!

Our Team wishes you a wonderful holiday season and a happy and prosperous 2018


bluebird bio Stock Soars on Unprecedented Blood Cancer Study Results

Shares of the clinical-stage biotech bluebird bio rose by as much as 23.9% in pre-market trading


bluebird, Celgene Tout ‘Unheard of’ Early-Stage Multiple Myeloma Data

There was a 94 percent overall response rate and a 56 percent complete response rate. However, at the time of the conference, three of the 10 complete responses weren’t confirmed


CROs and CRISPR/Cas9 service Offering

Charles River expands its CRISPR/Cas9 service offering with a license from ERS genomics


New Giro Health Open Initiative Seeks Answers to Neurodegenerative Diseases

The program, called Giro Health and introduced today, seeks to improve diagnosis and treatment of neurological and neurodegenerative diseases by combining several promising technologies.


Study suggests a way to stop HIV in its tracks

The finding raises the possibility of developing a drug that would prevent HIV-1 from binding to bicaudal D2, thus stranding the virus in the cytoplasm.

Get in touch

Subscribe to Eclosion Newsletter

 

CONTACT US
© 2016 Fondation Eclosion
All rights reserved
Webdesign: Comstone / Pierre Chassany
WordPress Development: Olivier Gisiger